A Spolight article about how the project using Imaging Mass Cytometry to characterise the lung tumour microenvironment in pre-clinical mouse models came about.
Immune Response to KRAS Inhibition | Fluidigm
Why do some people get sick when others don’t? Why are there such big differences in cancer diagnosis and progression among patients? What makes immunotherapy treatment work for one person but not another?
Febe van Maldegem, PhD, and Karishma Valand advanced a methodology focused on cancer cell behavior and generated novel insights into the mechanism of immunotherapy efficacy. Their work using Imaging Mass Cytometry in mouse models has led to valuable understanding of the immune cell response to cancer therapy.